In situ degradation: a new concept for system suitability tests in monographs of the European Pharmacopoeia.
Monographs of the European Pharmacopoeia describe in the LC-test for related substances usually a system suitability test in order to ensure the adequate separation of impurities. Since the reference substances required are often not available a recent approach to avoid this problem is the generation of the required impurity by 'in situ degradation' of the active principle. This paper describes some typical applications of this technique as well as recent examples, such as the controlled degradation of cefalotin sodium, imipenem and spiramycin.
Rose
U
U
Council of Europe, European Department for the Quality of Medicines, Strasbourg, France.
D002512:Cephalothin / Q000032:analysis; D002623:Chemistry Techniques, Analytical / Q000379:methods*; D002845:Chromatography / Q000379:methods*; D004340:Drug Contamination; D006868:Hydrolysis; D015378:Imipenem / Q000032:analysis; D010084:Oxidation-Reduction; D010602:Pharmacopoeias as Topic / Q000592:standards*; D015572:Spiramycin / Q000032:analysis
D015378:Imipenem; D015572:Spiramycin; D002512:Cephalothin